Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05714787
What this trial is testing

Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung Disease

Who this might be right for
OsteoporosisInterstitial Lung DiseaseVertebral Fracture
Centre Hospitalier Universitaire de Nice 202
Early research (Phase 1)Looking for participantsNCT06998706
What this trial is testing

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study

Who this might be right for
Interstitial Lung Disease (ILD)
Ruijin Hospital 10
Large-scale testing (Phase 3)Study completedNCT01979952
What this trial is testing

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 113
Testing effectiveness (Phase 2)Study completedNCT06081621
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 23
Large-scale testing (Phase 3)Study completedNCT02630316
What this trial is testing

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
United Therapeutics 326
Testing effectiveness (Phase 2)Study completedNCT02951429
What this trial is testing

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 177
Early research (Phase 1)Study completedNCT03727802
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Toray Industries, Inc 34
Large-scale testing (Phase 3)Ended earlyNCT01408836
What this trial is testing

Plasma Exchange for Renal Vasculitis

Who this might be right for
Wegener's GranulomatosisMicroscopic Polyangiitis
Cambridge University Hospitals NHS Foundation Trust 150
Early research (Phase 1)Study completedNCT02871401
What this trial is testing

A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vanderbilt University Medical Center 31
Not applicableStudy completedNCT00512967
What this trial is testing

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

Who this might be right for
Interstitial Lung DiseasesSarcoidosisIdiopathic Pulmonary Fibrosis+1 more
Maastricht University Medical Center 76
Testing effectiveness (Phase 2)Study completedNCT00530075
What this trial is testing

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

Who this might be right for
Wegener's Granulomatosis
Nippon Kayaku Co., Ltd. 45
Not applicableStudy completedNCT02268981
What this trial is testing

Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Schön Klinik Berchtesgadener Land 18
Testing effectiveness (Phase 2)Study completedNCT00162760
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Johns Hopkins University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Post-approval studies (Phase 4)Ended earlyNCT01321996
What this trial is testing

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 29
Not applicableWithdrawnNCT03182049
What this trial is testing

Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study

Who this might be right for
Granulomatosis With Polyangiitis
Vanderbilt University Medical Center
Not applicableUnknownNCT05372926
What this trial is testing

Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Interstitial Lung DiseasePulmonary Rehabilitation
ADIR Association 16
Early research (Phase 1)Study completedNCT05817240
What this trial is testing

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc. 21
Not applicableUnknownNCT03670576
What this trial is testing

It's Not JUST Idiopathic Pulmonary Fibrosis Study

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
University of Nottingham 250
Large-scale testing (Phase 3)Study completedNCT00662038
What this trial is testing

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 1,058
Next Page